[go: up one dir, main page]

WO2007135530A3 - Pharmaceutically & veterinarily suitable salt - Google Patents

Pharmaceutically & veterinarily suitable salt Download PDF

Info

Publication number
WO2007135530A3
WO2007135530A3 PCT/IB2007/001296 IB2007001296W WO2007135530A3 WO 2007135530 A3 WO2007135530 A3 WO 2007135530A3 IB 2007001296 W IB2007001296 W IB 2007001296W WO 2007135530 A3 WO2007135530 A3 WO 2007135530A3
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutically
suitable salt
veterinarily suitable
veterinarily
pyrrolidin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2007/001296
Other languages
French (fr)
Other versions
WO2007135530A2 (en
Inventor
Paul Vincent Fish
Florian Wakenhut
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd Great Britain
Original Assignee
Pfizer Ltd Great Britain
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd Great Britain filed Critical Pfizer Ltd Great Britain
Publication of WO2007135530A2 publication Critical patent/WO2007135530A2/en
Publication of WO2007135530A3 publication Critical patent/WO2007135530A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)

Abstract

An improved pharmaceutical and veterinarily acceptable salt of 2,3-dichloro-Ν-cyclopentyl-Ν-[(3S)- pyrrolidin-3-yl]benzamide and compositions thereof, is described.
PCT/IB2007/001296 2006-05-22 2007-05-10 Pharmaceutically & veterinarily suitable salt Ceased WO2007135530A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74787706P 2006-05-22 2006-05-22
US60/747,877 2006-05-22

Publications (2)

Publication Number Publication Date
WO2007135530A2 WO2007135530A2 (en) 2007-11-29
WO2007135530A3 true WO2007135530A3 (en) 2008-03-27

Family

ID=38723668

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2007/001296 Ceased WO2007135530A2 (en) 2006-05-22 2007-05-10 Pharmaceutically & veterinarily suitable salt

Country Status (4)

Country Link
JP (1) JP2007314534A (en)
AR (1) AR061055A1 (en)
TW (1) TW200815341A (en)
WO (1) WO2007135530A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004111003A1 (en) * 2003-06-17 2004-12-23 Pfizer Limited Amide derivatives as selective serotonin re-uptake inhibitors
WO2004110995A1 (en) * 2003-06-17 2004-12-23 Pfizer Limited N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004111003A1 (en) * 2003-06-17 2004-12-23 Pfizer Limited Amide derivatives as selective serotonin re-uptake inhibitors
WO2004110995A1 (en) * 2003-06-17 2004-12-23 Pfizer Limited N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors

Also Published As

Publication number Publication date
JP2007314534A (en) 2007-12-06
TW200815341A (en) 2008-04-01
AR061055A1 (en) 2008-07-30
WO2007135530A2 (en) 2007-11-29

Similar Documents

Publication Publication Date Title
WO2006086562A3 (en) Phenylazetidinone derivatives
AU2003296897A1 (en) Pharmaceutical formulations of camptothecine derivatives
AU2002363236A1 (en) Compounds, pharmaceutical compositions and methods of use therefor
WO2006069363A3 (en) Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride
WO2008049116A3 (en) Substituted indoles
WO2007135527A3 (en) Benzimidazolyl compounds
AU2003230700A1 (en) Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
AU2003240947A1 (en) Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
AU2003244632A1 (en) Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
AU2003244649A1 (en) Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
IL166621A0 (en) Polymorph of n-methyl-n-(3-ä-3-Ä2-thienylcarbonylÜ-pyrazol-Ä1,5-alphaÜpyrimidin-7-ylüacetamide and pharmaceutical compositions containing the same
AU2003291867A1 (en) Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of phex
WO2009060952A1 (en) Novel preparation
WO2007062338A3 (en) Solid formulations
WO2007110765A3 (en) Processes for the preparation of octreotide
WO2004056832A3 (en) Epothilone derivatives
EP1883619B8 (en) Process of preparation of substituted tetrafluorobenzylaniline compound and its pharmaceutically approved salts
WO2008039894A3 (en) Atorvastatin pharmaceutical compositions
AU2003303367A1 (en) Compositions of benzoquinolizine carboxylic acid antibiotic drugs
AU2003279392A1 (en) Pharmaceutical compositions of azithromycin
AU2003265373A1 (en) Preparation of aztreonam
WO2007135530A3 (en) Pharmaceutically & veterinarily suitable salt
WO2007015918A3 (en) Novel biologically active peptides and their new uses
WO2004072037A8 (en) 2,3'-bipyridines derivatives as selective cox-2 inhibitors
AU2003263480A1 (en) Oral pharmaceutical compositions of fenofibrate having high bioavailability

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07734604

Country of ref document: EP

Kind code of ref document: A2